Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib with Paclitaxel and Carboplatin in Platinum-Resistant Ovarian Cancer
NCT01402271Phase 2Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Jul 2012
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of pazopanib in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by European Organisation for Research and Treatment of Cancer. Started Jul 2012; status: completed.
02
Drugs
pazopanib
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT01402271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01402271.